Strategic Program Cancer nieuws
Increased risk of cardiovascular disease in women treated for breast cancer can be predicted
Automated analysis of breast cancer patients’ routine scans can predict which women have a greater than one in four risk of going on to develop cardiovascular disease, according to research presented at the 12th European Breast Cancer Conference.
Read moreLarge variation in histologic grading of breast cancer between pathology laboratories
Quality improvement of biomarker assessment in breast cancer
Read moreOver € 4 million for cancer research in Utrecht
The Dutch Cancer Society (DCS) is investing 4.4 million in 8 studies at Utrecht Science Park. It concerns 5 studies at UMC Utrecht, 2 at the Hubrecht Institute and 1 at the Helen Dowling Institute.
Read moreWarm plea for the Innovation Clinic
“We have to organize our care in such a way that we can actually learn from each patient without losing valuable information. A so-called innovation clinic makes that possible.” Prof. Lenny Verkooijen makes a warm plea for this in a short webinar about ‘learning from implementation’, organized by the Information Council of the Dutch Health Department.
Read moreMedicatietest op gekweekte eierstoktumor is mogelijk
Sinds kort is het mogelijk om bij eierstokkanker uit tumorcellen van een patiënt in het lab mini-eierstoktumoren te kweken om daar medicijnen op te testen. Arts-onderzoeker Chris de Witte laat zien dat de reactie van deze mini-tumoren op geneesmiddelen vrij nauwkeurig de reactie bij deze patiënt voorspelt. Ook DNA-kenmerken van de tumor lijken medebepalend voor het behandelsucces. In de toekomst kunnen deze bevindingen mogelijk helpen om patiënten een behandeling op maat te bieden en zo de overlevingskans te vergroten.
Read moreImproving primary care involvement in cancer care
Thesis dr. Ietje Perfors, Improving primary care involvement in cancer care
Read moreLive from University Hall Lecture Dennis Klomp
For the first time in 384 years, an inaugural lecture will be broadcast live from the University Hall. The scoop is for Professor Dennis Klomp with his lecture, entitled "Powerful Exchange in Images".
Read moreThe RASTRIC trial: new investigator driven clinical trial started
Recently, Hugo Snippert and Hans Bos (both CMM in the UMCU) found a combination of three readily available drugs, that was effective in the lab on models of this disease. Excitingly, this month a phase I/II clinical trial based on their work has officially started. The RASTRIC trial is a first-in-human clinical trial to test this new combination. The trial is led by medical oncologist Jeanine Roodhart and is open for registration.
Read moreCancer mutations convert an inhibitory protein into an accelerator for tumor growth
Cancer-inhibiting proteins, so-called tumor suppressors, play an important role in the prevention of uncontrolled cell division. This prevents tumor formation; similar to a brake in a car. Researchers from the UMC Utrecht have now shown that the generation of a fragment of these proteins leads to a switch in their function, turning the brake into a gas pedal. These insights generate a better starting point for new and more precise treatments.
Read moreNew research into childhood cancer
The Princess Máxima Center and UMC Utrecht recently signed a new and promising collaboration agreement.
Read more